1. Home
  2. EVTL vs ABEO Comparison

EVTL vs ABEO Comparison

Compare EVTL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$2.16

Market Cap

338.7M

Sector

Industrials

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.46

Market Cap

307.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
ABEO
Founded
2016
1974
Country
United Kingdom
United States
Employees
454
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.7M
307.5M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
EVTL
ABEO
Price
$2.16
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$12.70
$20.00
AVG Volume (30 Days)
2.8M
1.0M
Earning Date
03-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.16
EPS
N/A
N/A
Revenue
N/A
$2,998,000.00
Revenue This Year
N/A
$1,024.31
Revenue Next Year
N/A
$145.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
258.18
52 Week Low
$1.90
$4.00
52 Week High
$7.60
$7.54

Technical Indicators

Market Signals
Indicator
EVTL
ABEO
Relative Strength Index (RSI) 34.19 46.84
Support Level $1.90 $5.20
Resistance Level $2.89 $5.54
Average True Range (ATR) 0.19 0.24
MACD -0.03 -0.01
Stochastic Oscillator 2.68 39.88

Price Performance

Historical Comparison
EVTL
ABEO

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: